Back to search

Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer

Data up to Jan 2025

Published1990
Citations124
References27

Total Citations Per Year

Abstract

References (27)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1965 • 3,333 citations

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

1987 • 2,447 citations

Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging

1974 • 2,200 citations

Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients

1989 • 877 citations

Purification of a Human Prostate Specific Antigen

2016 • 844 citations

PATTERNS OF PROGRESSION IN PROSTATE CANCER

1986 • 592 citations

PURIFICATION OF HUMAN PROSTATE SPECIFIC ANTIGEN

1979 • 547 citations

Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic Cancer

1987 • 313 citations

Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. I. Untreated Patients

1989 • 269 citations

Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radiation Treated Patients

1989 • 230 citations

Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. IV. Anti-Androgen Treated Patients

1989 • 212 citations

Use of human prostate-specific antigen in monitoring prostate cancer.

1981 • 192 citations

Carcinoma of the prostate.

1956 • 115 citations

Carcinoma of the prostate. Hormonal therapy

1987 • 103 citations

Relative Reliability of Five Serially Measured Markers for Prognosis of Progression in Prostate Cancer<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

1986 • 103 citations

An Evaluation of Prostate Specific Antigen in Prostatic Cancer

1987 • 96 citations

Criteria for Evaluating Patient Responses to Treatment Modalities for Prostatic Cancer

1984 • 86 citations

Comparative Experimental Study of the Serum Prostate Specific Antigen and Prostatic Acid Phosphatase in Serially Transplantable Human Prostatic Carcinoma Lines in Nude Mice

1988 • 50 citations

The use of Multiple Variables to Predict Response to Endocrine Therapy in Carcinoma of the Prostate: A Preliminary Report

1984 • 44 citations

Measurements of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate.

1986 • 43 citations

Transrectal Ultrasonography in the Followup of Prostatic Carcinoma Patients: A New Prognostic Parameter?

1984 • 43 citations

The Role of Serum Prostatic Acid Phosphatase as a Tumor Marker in Men with Advanced Adenocarcinoma of the Prostate

1984 • 35 citations

Immunoreactive Prostatic Acid Phosphatase Inprostatic Cancer: Diagnosis and Followup of Patients

1985 • 27 citations

Transrectal ultrasonometry of the prostate: the prognostic relevance of volume changes under endocrine management

1986 • 21 citations

Multiple Marker Evaluation in Prostatic Cancer Using Prostatic Specific Antigen, Gamma-Seminoprotein and Prostatic Acid Phosphatase

1989 • 12 citations

Cited By (0)

Loading...
Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic… (1990) – The Journal of Urology | Metascience Observatory Explorer